Screener
Royalty Pharma RPRX Provision For Other Credit Losses
Provision For Other Credit Losses at other companies
Other financials
Where this comes from
Reported directly by Royalty Pharma in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForOtherCreditLosses.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's provision for other credit losses?
- Royalty Pharma (RPRX) reported provision for other credit losses of $268.22M in Q2 2026.
- How has Royalty Pharma's provision for other credit losses changed year-over-year?
- Royalty Pharma's provision for other credit losses increased by 231.5% year-over-year, from -$203.94M to $268.22M.
- What is the long-term trend for Royalty Pharma's provision for other credit losses?
- Over 3 years (2021 to 2025), Royalty Pharma's provision for other credit losses has grown at a -11.0% compound annual growth rate (CAGR), from $452.84M to -$318.94M.
- What does provision for other credit losses mean?
- Provision For Other Credit Losses as reported by Royalty Pharma plc Class A Ordinary Shares.
Ask your AI about Royalty Pharma's provision for other credit losses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude